Long intergenic non-protein coding RNA 2625 (LINC02625)

Long intergenic non-protein coding RNA 2625 (LINC02625) is a member of the long intergenic non-coding RNA (lincRNA) family, a class of non-coding RNA molecules longer than 200 nucleotides that do not overlap annotated protein-coding genes[3][1]. LincRNAs, including LINC02625, are transcribed autonomously and are involved in regulating gene expression via numerous mechanisms, such as chromatin remodeling, modulating nuclear architecture, acting as scaffolds for proteins, stabilizing or destabilizing messenger RNAs, and participating in transcriptional regulation[1]. While lincRNAs have been broadly associated with gene regulatory networks, tissue specificity, and fine-tuning neighboring gene expression, the functional roles of specific lincRNAs—including LINC02625—are still largely uncharacterized, and direct links to disease contexts or therapeutic modulation have not been established[3][1]. LINC02625 does not code for a protein, and there is no evidence that it serves as a therapeutic target, biomarker, or drug-interacting molecule; its roles are consistent with regulatory non-coding RNAs involved in gene expression control, chromatin dynamics, and possibly RNA stabilization[1][3]. Key fields lacking information, such as known disease roles, interacting drugs, or safety concerns, likely reflect the general lack of functional characterization for this specific lincRNA rather than incorrect nomenclature or technical problems in its naming conventions.

Other names

LINC02625